274.91USD+3.57%Mkt Cap: 53.49B USDP/E: 21.05Last update: 2026-05-22
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…
Industry Peers
Medical Distributionloading…
Indicators:|
Key Statistics
Company
Market Cap53.49B USD
Enterprise Value64.75B USD
Revenue (TTM)328.68B USD
Gross Profit11.48B USD
Net Income (TTM)1.55B USD
Revenue/Share1693.17 USD
Last Price274.91 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees47.0K
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)21.05
P/E (Forward)13.42
PEG0.64
EV/EBITDA12.21
EV/Revenue0.20
P/S0.16
P/B15.20
EPS (TTM)13.06
EPS (Forward)19.77
52W Range
244.8223% of range377.54
52W High377.54 USD
52W Low244.82 USD
Profitability
Gross Margin3.57%
Oper. Margin1.72%
EBITDA Margin1.61%
Profit Margin0.48%
ROE103.06%
ROA2.03%
Growth
Revenue Growth3.80%
Earnings Growth128.30%
Cash Flow & Leverage
Operating CF3.88B USD
CapEx (TTM)667.98M USD
FCF Margin-0.10%
FCF Yield-0.59%
Net Debt12.92B USD
Net Debt/EBITDA2.44
Balance Sheet
Debt/Equity5.08
Current Ratio0.95
Quick Ratio0.48
Book Value/Sh17.46 USD
Cash/Share11.19 USD
Dividends
Fwd Div Rate2.400 USD
Trail. Div Rate2.300 USD
Div. Yield0.90%
5Y Avg Yield1.02%
Payout Ratio17.62%
Ex-Div DateMay 15, 2026
Pay DateJun 1, 2026
Splits
Last Split2:1
Split DateJun 16, 2009
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)357.00 USD
Target Range280.00 USD – 425.00 USD
# Analysts12
Ownership
Shares Out.194.56M
Float184.02M
Insiders4.23%
Institutions98.36%
Short Interest
Short Ratio3.8d
Short % Float3.03%
Short % Out.2.67%
Shares Short5.19M
Short (prev mo.)5.16M
Technical
SMA 50305.90 (-10.1%)
SMA 200326.53 (-15.8%)
Beta0.65
S&P 52W Chg28.31%
Avg Vol (30d)2.04M
Avg Vol (10d)2.31M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—